-
Posted by
Two Blokes Jun 6 -
Filed in
Stock
-
6 views
Centene is a dominant, diversified insurer with strong positions in Medicaid, ACA, and Medicare Part D, serving nearly 29 million members. Q1 2025 results exceeded expectations, with robust revenue growth, improved margins, and management raising full-year revenue guidance. Valuation models indicate a fair value of $60 per share, offering 9% upside; downside risk is limited, and FCF assumptions are conservative.
